Newly published research from Essilor has suggested an investment of US $14 billion (AU$21 b) over the next 30 years could be enough to eliminate uncorrected poor vision due to refractive errors worldwide. Read more
Transitions announces a new style ambassador
Essilor Australia has announced Ms Tegan Martin, former Miss Universe Australia and 2019 Melbourne Cup style ambassador, as style ambassador for its ‘Transitions Style Academy’ campaign. Read more
Heidelberg Engineering moves to upgraded premises
Ophthalmic device manufacturer and distributor Heidelberg Engineering has opened a new Australian support centre in Melbourne. Read more
OPSM establishes flagship store in Sydney CBD
Local eyecare retailer OPSM has opened its largest ‘flagship’ store, following a major upgrade and expansion of an existing inner Sydney location. Read more
Glaukos to acquire Avedro
Pioneer in micro-invasive glaucoma surgery (MIGS) Glaukos has announced it will acquire US-based ophthalmic pharmaceutical and medical technology developer Avedro. Read more
Sudden departure prompts leadership change at Ellex
Experienced global healthcare executive Mr Ged Wallace has resigned as CEO of Ellex Medical Lasers, after serving just three and a half months in the role. Read more
EssilorLuxottica targets GrandVision takeover
EssilorLuxottica is in discussions to purchase a majority stake in GrandVision, the multi-national Dutch eyewear retailer with more than 7,000 stores worldwide. Read more
Oscar Wylee enters Western Australia with two stores
Vision Direct has partnered with the World Wide Fund for Nature Australia (WWF-Australia) to trial a recycling program to repurpose ocean plastics into sunglasses. Read more
LEI appoints respected WA business leader to board
The Lions Eye Institute (LEI) has appointed experienced scientist, geologist and award-winning business executive Dr Erica Smyth to its board of directors. Read more
Pioneering surgeon completes world?s first AMD gene therapy
Professor Robert MacLaren completed the landmark procedure on 80-year-old British woman Mrs Janet Osborne, of Oxford, in a clinical trial at the John Radcliffe Read more